Arrivent Biopharma Inc (AVBP)

EBITDA Growth

-58.90%

Quarterly · Period ending:

AVBP logo

AVBP EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported-58.90%
AVBP Quarterly EBITDA YoY % (-1.42% → -58.90%)
High-resolution chart · PNG

AVBP ebitda growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Arrivent Biopharma Inc EBITDA Growth — Quarterly
Period endingEBITDA Growth
-58.9%
32.7193%
-72.2677%
-70.0934%
-43.5448%
-269.679%
2.6424%
-42.7956%
-1.4235%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.